FAME II: FFR-guided PCI reduces urgent reinterventions, but not change mortality, MI

Final results of the FAME II trial comparing fractional flow reserve-guided coronary interventions with medical therapy alone are now published. The trial was stopped early, but the controversy about the meaning of its findings has not.

via The Heart